Holen Sie sich die Stockscreener-App
0.628
7.17%
0.042
Handel nachbörslich:
.63
0.002
+0.32%
Finanzdaten der Rein Therapeutics Inc-Aktie (RNTX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
| Operating Expenses |
16.18%
6.076
|
5.23 | 32.66 | 5.492 | 6.871 |
| Operating Income/Loss |
16.18%
-6.076
|
-5.23 | -32.66 | -5.492 | -6.871 |
| Net Income/Loss |
9.20%
-6.375
|
-5.838 | -31.97 | -5.581 | -6.822 |
| Basic Average Shares |
121.00%
67.08
|
30.35 | - | 26.36 | 24.19 |
| Diluted Average Shares |
121.00%
67.08
|
30.35 | - | 26.36 | 24.19 |
| Basic Earnings Per Share |
47.37%
-0.10
|
-0.19 | - | -0.21 | -0.28 |
| Diluted Earnings Per Share |
47.37%
-0.10
|
-0.19 | - | -0.21 | -0.28 |
| Common Stock Dividends |
-
|
- | - | - | - |
1.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):